Current Issue June 2012, Vol. 6, No. 5

Issue Highlights

Identification of areas of functioning and disability addressed in inflammatory bowel disease-specific patient reported outcome measures
June 2012(Vol. 6 | No. 5 | Pages 507-517)
Ulrike Achleitner, Michaela Coenen, Jean-Frédéric Colombel, Laurent Peyrin-Biroulet, Narine Sahakyan, Alarcos Cieza

Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases
June 2012(Vol. 6 | No. 5 | Pages 518-523)
Iván Guerra, Alicia Algaba, José Lázaro Pérez-Calle, María Chaparro, Ignacio Marín-Jiménez, Raquel García-Castellanos, Yago González-Lama, Antonio López-Sanromán, Noemí Manceñido, Pilar Martínez-Montiel, Elvira Quintanilla, Carlos Taxonera, Mónica Villafruela, Alberto Romero-Maté, Pilar López-Serrano, Javier P. Gisbert, Fernando Bermejo

Mortality in ulcerative colitis and Crohn's disease. A population-based study in Finland
June 2012(Vol. 6 | No. 5 | Pages 524-528)
Pia Manninen, Anna-Liisa Karvonen, Heini Huhtala, Martin Rasmussen, Maarit Salo, Leena Mustaniemi, Ismo Pirttiniemi, Pekka Collin

Management of inflammatory bowel disease in pregnancy
18 May 2012
Séverine Vermeire, Franck Carbonnel, Pierre G. Coulie, Vincent Geenen, Johanna M.W. Hazes, Pierre L. Masson, Filip De Keyser, Edouard Louis
Abstract: Background and Aims: Inflammatory bowel disease (IBD) is a chronic disease affecting mainly young people in their reproductive years. IBD therefore has a major impact on patients’ family pla...
Reply to Dr. Chouchana's letter
17 May 2012
Ulf Hindorf, Malin Lindqvist Appell
We would like to thank Dr. Chouchana for the comments on our manuscript and thereby giving us the opportunity to discuss this important topic again.
Reply to Dr. McNabb-Baltar's letter
17 May 2012
Ashwin N. Ananthakrishnan
We thank the interest shown in our manuscript by Dr. McNabb-Baltar and agree that identification of risk factors for infectious complications in patients with inflammatory bowel disease (IBD) is an im...
Proinflammatory cytokines induce crosstalk between colonic epithelial cells and subepithelial myofibroblasts: Implication in intestinal fibrosis
11 May 2012
Ioannis Drygiannakis, Vassilis Valatas, Ourania Sfakianaki, Leonidas Bourikas, Pinelopi Manousou, Konstantinos Kambas, Konstantinos Ritis, George Kolios, Elias Kouroumalis
Abstract: Background and aims: Colonic epithelial cells and adjacent subepithelial myofibroblasts are important counterparts in the pathogenesis of intestinal inflammation and fibrosis. We investigate...
The “hygiene hypothesis” in IBD
07 May 2012
Richard B. Gearry, Andrew J. Dodgshun
We read with interest the paper by Castiglione et al. investigating the role of hygiene hypothesis related as potential risk factors for the development of inflammatory bowel disease (IBD). This study...

View More Articles in Press...

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis
February 2010 (Vol. 4 | No. 1 | Pages 7-27)
Gert Van Assche, Axel Dignass, Julian Panes, Laurent Beaugerie, John Karagiannis, Mathieu Allez, Thomas Ochsenkühn, Tim Orchard, Gerhard Rogler, Edouard Louis, Limas Kupcinskas, Gerassimos Mantzaris, Simon Travis, Eduard Stange, for the European Crohn's and Colitis Organisation (ECCO)
- Full Text
- PDF (364 KB)
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
March 2008 (Vol. 2 | No. 1 | Pages 1-23)
E.F. Stange, S.P.L. Travis, S. Vermeire, W. Reinisch, K. Geboes, A. Barakauskiene, R. Feakins, J.F. Fléjou, H. Herfarth, D.W. Hommes, L. Kupcinskas, P.L. Lakatos, G.J. Mantzaris, S. Schreiber, V. Villanacci, B.F. Warren, for the European Crohn's and Colitis Organisation (ECCO)
- Full Text
- PDF (471 KB)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
February 2010 (Vol. 4 | No. 1 | Pages 28-62)
A. Dignass, G. Van Assche, J.O. Lindsay, M. Lémann, J. Söderholm, J.F. Colombel, S. Danese, A. D'Hoore, M. Gassull, F. Gomollón, D.W. Hommes, P. Michetti, C. O'Morain, T. Öresland, A. Windsor, E.F. Stange, S.P.L. Travis, for the European Crohn's and Colitis Organisation (ECCO)
- Full Text
- PDF (609 KB)
European evidence-based Consensus on the management of ulcerative colitis: Current management
March 2008 (Vol. 2 | No. 1 | Pages 24-62)
S.P.L. Travis, E.F. Stange, M. Lémann, T. Øresland, W.A. Bemelman, Y. Chowers, J.F. Colombel, G. D'Haens, S. Ghosh, P. Marteau, W. Kruis, N.J.McC. Mortensen, F. Penninckx, M. Gassull, for the European Crohn's and Colitis Organisation (ECCO)
- Full Text
- PDF (587 KB)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
February 2010 (Vol. 4 | No. 1 | Pages 63-101)
Gert Van Assche, Axel Dignass, Walter Reinisch, C. Janneke van der Woude, Andreas Sturm, Martine De Vos, Mario Guslandi, Bas Oldenburg, Iris Dotan, Philippe Marteau, Alessandro Ardizzone, Daniel C. Baumgart, Geert D'Haens, Paolo Gionchetti, Francisco Portela, Boris Vucelic, Johan Söderholm, Johanna Escher, Sibylle Koletzko, Kaija-Leena Kolho, Milan Lukas, Christian Mottet, Herbert Tilg, Séverine Vermeire, Frank Carbonnel, Andrew Cole, Gottfried Novacek, Max Reinshagen, Epameinondas Tsianos, Klaus Herrlinger, Bas Oldenburg, Yoram Bouhnik, Ralf Kiesslich, Eduard Stange, Simon Travis, James Lindsay, for the European Crohn's and Colitis Organisation (ECCO)
- Full Text
- PDF (607 KB)

On the Cover

New Issue Alert

Free Trial Issue

Companion Journal

FREE with your Journal of Crohn's and Colitis Subscription!

ECCO Information

The mission of the European Crohn's and Colitis Organisation (ECCO) is to strive for optimized care for patients with inflammatory bowel diseases (IBD) in all aspects. To this end, ECCO will adopt and further all efforts that lead to an improvement in the use of current therapies and procedures, develop guidelines with the highest possible process and content quality, and define better and more valid outcome parameters for the therapy of IBD. In addition, ECCO promotes the specialist, postgraduate education in IBD and scientific projects in IBD.

Access this journal onSciVerse ScienceDirect

About CROHNS

The Journal of Crohn's and Colitis is the official journal of the European Crohn's and Colitis Organisation (ECCO) and is concerned with the dissemination of knowledge on clinical, basic science and innovative methods related to inflammatory bowel diseases. The journal publishes original articles, review papers, editorials, leading articles, viewpoints, case reports, innovative methods and letters to the editor. All submitted material is subject to a peer-review process. Supplemental issues of the journal are published under a separate title, Journal of Crohn's and Colitis Supplements.

Journal Access

Access to abstracts is complimentary. Access to full text is limited to print subscribers.

Members of the European Crohn's and Colitis Organisation (ECCO) receive a subscription to the Journal of Crohn's and Colitis as part of their membership benefits. To become a member of ECCO, please visit the ECCO website.

Journal Ranking

Impact Factor of this journal
2010 impact factor: 2.628
© Journal Citation Reports 2011, published by Thomson Reuters

Publishing Information

The Journal of Crohn's and Colitis is published for the European Crohn's and Colitis Organisation (ECCO) by Elsevier.